As of 2026-09-20, the Relative Valuation of Pulse Biosciences Inc (PLSE) is (39.06) USD. This relative valuation is based on P/E multiples. With the latest stock price at 53.87 USD, the upside of Pulse Biosciences Inc based on Relative Valuation is -172.5%.
The range of the Relative Valuation is (38.14) - (39.73) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 35.4x - 44.8x | 40.8x |
| Forward P/E multiples | 25.9x - 36.9x | 31.8x |
| Fair Price | (38.14) - (39.73) | (39.06) |
| Upside | -170.8% - -173.8% | -172.5% |
| Date | P/E |
| 2026-09-16 | -46.05 |
| 2026-09-15 | -51.23 |
| 2026-09-14 | -50.32 |
| 2026-09-11 | -49.29 |
| 2026-09-10 | -50.52 |
| 2026-09-09 | -49.16 |
| 2026-09-08 | -45.28 |
| 2026-09-04 | -49.42 |
| 2026-09-03 | -50.78 |
| 2026-09-02 | -48.90 |
| 2026-09-01 | -48.35 |
| 2026-08-31 | -46.71 |
| 2026-08-28 | -44.15 |
| 2026-08-27 | -45.07 |
| 2026-08-26 | -44.64 |
| 2026-08-25 | -45.48 |
| 2026-08-24 | -45.60 |
| 2026-08-21 | -46.80 |
| 2026-08-20 | -44.41 |
| 2026-08-19 | -43.64 |
| 2026-08-18 | -42.70 |
| 2026-08-17 | -43.43 |
| 2026-08-14 | -41.34 |
| 2026-08-13 | -41.69 |
| 2026-08-12 | -40.21 |
| 2026-08-11 | -41.21 |
| 2026-08-10 | -38.53 |
| 2026-08-07 | -39.36 |
| 2026-08-06 | -35.49 |
| 2026-08-05 | -35.18 |
| 2026-08-04 | -35.43 |
| 2026-08-03 | -35.02 |
| 2026-07-31 | -32.61 |
| 2026-07-30 | -32.52 |
| 2026-07-29 | -31.79 |
| 2026-07-28 | -32.92 |
| 2026-07-27 | -30.43 |
| 2026-07-24 | -28.06 |
| 2026-07-23 | -28.77 |
| 2026-07-22 | -30.41 |
| 2026-07-21 | -28.09 |
| 2026-07-20 | -26.88 |
| 2026-07-17 | -26.62 |
| 2026-07-16 | -25.41 |
| 2026-07-15 | -24.43 |
| 2026-07-14 | -23.63 |
| 2026-07-13 | -24.03 |
| 2026-07-10 | -24.40 |
| 2026-07-09 | -25.28 |
| 2026-07-08 | -26.09 |